Matcham George 4

What Happened

• George Matcham, a director of Instil Bio, received a derivative equity award on 2026-06-11 to acquire 6,500 shares at a $0.00 price (reported as an "A" grant). No cash was paid for the award at grant; it is an option-style award that will vest over time rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-12 (appears timely).
• Transaction type/code: A (award/grant) — derivative security.
• Amount: 6,500 shares; reported price: $0.00 (no cash paid at grant).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (vesting): The option vests in 12 substantially equal monthly installments starting July 11, 2026, subject to continuous service. Any portion not vested by the next annual stockholder meeting will vest in full (subject to service). Full vesting also occurs on death, Disability, or a Change in Control.

Context

• This was an equity award to a board director (not an open-market buy). Derivative awards typically do not convert to actual shares until vesting (and possibly exercise), so they are different from immediate purchases or sales. The $0.00 price indicates no purchase price at grant; the filing does not show immediate sale or cashless exercise.